Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gross Profit | $14.1M | $7,846.0K | $27.6M | $34.4M | $3,919.0K | $9,265.0K | $169.9M | $94.5M | $296.9M | $354.3M | $508.5M | $726.8M | $1,047.5M | $1,456.7M | $1,787.8M | $2,044.5M | $2,535.4M | $2,835.3M | $3,187.6M | $3,440.6M |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Incyte Corporation's last 12-month Gross Profit is $3,766.1M, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Incyte Corporation's Gross Profit growth was 11.9%. The average annual Gross Profit growth rates for Incyte Corporation have been 13.6% over the past three years, 13.5% over the past five years.